Your browser doesn't support javascript.
loading
The Efficacy of Kohl (Surma) and Erythromycin in Treatment of Blepharitis: An Open-Label Clinical Trial.
Karbassi, Esmat; Amiri-Ardekani, Ehsan; Farsinezhad, Alireza; Shahesmaeili, Armita; Abhari, Yasaman; Ziaesistani, Mahsa; Pouryazdanpanah, Noushin; Derakhshani, Ali; Jamshidi, Fatemeh; Tajadini, Haleh.
Afiliação
  • Karbassi E; Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
  • Amiri-Ardekani E; Department of Phytopharmaceuticals (Traditional Pharmacy), Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Farsinezhad A; Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Shahesmaeili A; Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Abhari Y; Cell Therapy and Regenerative Medicine Comprehensive Center, Kerman University of Medical Sciences, Kerman, Iran.
  • Ziaesistani M; Department of Hematology and Laboratory Sciences, Faculty of Allied Medical Sciences, Kerman University of Medical Sciences, Kerman, Iran.
  • Pouryazdanpanah N; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
  • Derakhshani A; Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.
  • Jamshidi F; Cell Therapy and Regenerative Medicine Comprehensive Center, Kerman University of Medical Sciences, Kerman, Iran.
  • Tajadini H; Department of Hematology and Laboratory Sciences, Faculty of Allied Medical Sciences, Kerman University of Medical Sciences, Kerman, Iran.
Article em En | MEDLINE | ID: mdl-35111228

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Evid Based Complement Alternat Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Evid Based Complement Alternat Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã